[CAS NO. 16611-84-0]  Anacardic Acid

Ships within Stock Price Qty Total
$0.00
$0.00
Please click "REQUEST A QUOTE" button if you need other sizes or custom synthesis
request a quote
If there is no stock, or you need other sizes or custom synthesis, please:

PRODUCTS SPECIFICATIONS [16611-84-0]

Store
Catalog
HY-N2020
Brand
MCE
CAS
16611-84-0

DESCRIPTION [16611-84-0]

Overview

MDLMFCD07368254
Molecular Weight348.52
Molecular FormulaC22H36O3
SMILESO=C(O)C1=C(CCCCCCCCCCCCCCC)C=CC=C1O

For research use only. We do not sell to patients.


Summary

Anacardic Acid, extracted from cashew nut shell liquid, is a histone acetyltransferase inhibitor, inhibits HAT activity of p300 and PCAF, with IC 50 s of ∼8.5 μM and ∼5 μM, respectively.


IC50 & Target

p300-HAT

8.5 μM (IC 50 )

PCAF

5 μM (IC 50 )


In Vitro

Anacardic Acid is a histone acetyltransferase, inhibits HAT activity of p300 and PCAF, with IC 50 s of ∼8.5 μM and ∼5 μM, respectively [1] . Anacardic Acid (300 μM) inhibits mycelial growth. Anacardic Acid (50 μM) induces apoptosis-like characteristics in M. oryzae , and the effect is caspase independent. Anacardic Acid (1-80 μM) leads to loss of mitochondrial potential. Anacardic Acid (1-60 μM) also exhibits antioxidant activity in M. oryzae [3] .

MCE has not independently confirmed the accuracy of these methods. They are for reference only.


In Vivo

Anacardic acid (5 mg/kg, i.p.) attenuates the binding of HATs to the promoter of MEF2A and reverse hyperacetylation of H3K9ac caused by phenylephrine in C57BL/6 mice. Anacardic acid inhibits the level of transcription on MEF2A and cardiac development-related downstream genes, attenuates the protein overexpression of cardiac downstream genes caused by phenylephrine, reverses and attenuates cardiac hypertrophy in the hearts of mice exposed to phenylephrine, and attenuates the left ventricular pressure and improves cardiac function in the cardiac hypertrophy mice [2] .

MCE has not independently confirmed the accuracy of these methods. They are for reference only.


Appearance

Solid



Shipping

Room temperature in continental US; may vary elsewhere.


Storage

Powder -20°C 3 years
4°C 2 years
In solvent -80°C 6 months
-20°C 1 month

Solvent & Solubility

In Vitro:

DMSO : 100 mg/mL ( 286.93 mM ; Need ultrasonic)

Preparing
Stock Solutions
Concentration Solvent Mass 1 mg 5 mg 10 mg
1 mM 2.8693 mL 14.3464 mL 28.6928 mL
5 mM 0.5739 mL 2.8693 mL 5.7386 mL
10 mM 0.2869 mL 1.4346 mL 2.8693 mL
* Please refer to the solubility information to select the appropriate solvent.
In Vivo:
  • 1.

    Add each solvent one by one: 10% DMSO >> 90% (20% SBE-β-CD in saline)

    Solubility: 10 mg/mL (28.69 mM); Suspended solution; Need ultrasonic

  • 2.

    Add each solvent one by one: 10% DMSO >> 40% PEG300 >> 5% Tween-80 >> 45% saline

    Solubility: 2.5 mg/mL (7.17 mM); Suspended solution; Need ultrasonic

  • 3.

    Add each solvent one by one: 10% DMSO >> 90% corn oil

    Solubility: ≥ 2.5 mg/mL (7.17 mM); Clear solution

* All of the co-solvents are available by MCE.


Synonyms

Benzoic acid, 2-hydroxy-6-pentadecyl-
Salicylic acid, 6-pentadecyl-
2-Hydroxy-6-pentadecylbenzoic acid
1-Hydroxy-2-carboxy-3-pentadecylbenzene
(15:0)-Anacardic acid
6-Pentadecylsalicylic acid
Cyclogallipharic acid
Hydroginkgolic acid
22:0-Anacardic acid
NSC 229596
NSC 333857
NSC 623096
6-Pentadecyl-2-hydroxybenzoic acid
Hydrogenated anacardic acid
Ginkgolic acid C15:0